Skip to content
  • French
  • English
  • Dutch
Laboratoires Delbert Logo Laboratoires Delbert Logo Laboratoires Delbert Logo
  • The Laboratory
  • Vision
  • Expertise
  • Products
  • International
  • Partners
  • Commitments
  • News
  • Contact
  • The Laboratory
  • Vision
  • Expertise
  • Products
  • International
  • Partners
  • Commitments
  • News
  • Contact
  • The Laboratory
  • Vision
  • Expertise
  • Products
  • International
  • Partners
  • Commitments
  • News
  • Contact

European marketing authorizations for Timentin®

Home/News/European marketing authorizations for Timentin®
European marketing authorizations for Timentin®
2022-01-14T14:49:53+00:00August 3rd, 2020|

Actualités / News

  • Availability of Prostaphlin® 1000 mg for Czech market 26/01/2023
  • Commercialization of amoxicilline in Ireland 16/01/2023
  • THE LABORATOIRES DELBERT ANNOUNCES A SERVICES AGREEMENT WITH IBI 30/11/2022
  • Acquisition de TERALITHE® par les Laboratoires Delbert 05/07/2022
  • Acquisition of TERALITHE® by the Laboratoires Delbert 17/05/2022
  • Laboratoires Delbert – Help to Ukraine 14/04/2022
  • Augmentin® injectable devient Levmentin® : informations et dates de mise à disposition 07/03/2022
  • AUGMENTIN 1G/200mg 1bte modèle ville – Rupture de stock / Rétrocession hospitalière 14/02/2022
  • Information Piportil®, Laboratoires Delbert 31/01/2022
  • Rupture de stock de Clamoxyl® 500mg 07/01/2022
Logo Laboratoires Delbert

49, rue Rouelle
75015 Paris
France
Phone + 33 1 46 99 68 20

Download the company information sheet of the Laboratoires Delbert

  • Legal mentions & Terms and conditions of use
  • Contact
All rights reserved to the Laboratoires Delbert© . RCS Paris 443 960 570 - SAS with capital of 216 202 €
Page load link
  • French
  • English
  • Dutch
Go to Top